Inasmuch as several regular posters on this board are invested in ENTA and/or GILD, I’m surprised no one commented on the HCV-pricing estimates in #msg-100491031.
If any readers think the estimates in #msg-100491031 are off-base, I encourage them to post their own numbers rather than to offer strictly qualitative feedback. T.i.a. Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”